ALX-0061 Phase I Bioavailability Study in Healthy Volunteers
NCT02101073
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
70
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL:
ALX-0061
BIOLOGICAL:
ALX-0061
Sponsor
Ablynx, a Sanofi company